Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Tax Provisions (2023)

Mereo BioPharma (MREO) has disclosed Tax Provisions for 1 consecutive years, with -$532000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Tax Provisions changed N/A to -$532000.0 in Q4 2023 year-over-year; TTM through Sep 2024 was -$532000.0, a N/A change, with the full-year FY2023 number at -$532000.0, down 174.09% from a year prior.
  • Tax Provisions was -$532000.0 for Q4 2023 at Mereo BioPharma.
  • In the past five years, Tax Provisions ranged from a high of -$532000.0 in Q4 2023 to a low of -$532000.0 in Q4 2023.